Yuyu Pharma, Inc. (KRX:000220)
South Korea · Delayed Price · Currency is KRW 3,885.00
+45.00 (1.17%)
Last updated: Sep 1, 2026, 1:19 PM KST
Yuyu Pharma Market Cap
Yuyu Pharma has a market cap or net worth of 60.47 billion as of September 1, 2026. Its market cap has decreased by -11.91% in one year.
Market Cap
60.47B
Enterprise Value
72.05B
Revenue
144.37B
Ranking
n/a
PE Ratio
5.52
Stock Price
3,885.00
ChartMarket Cap Chart
Since August 31, 1995, Yuyu Pharma's market cap has increased from 11.10B to 60.47B, an increase of 444.61%. That is a compound annual growth rate of 5.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 62.05B | -12.74% |
| Dec 30, 2025 | 71.10B | -2.47% |
| Dec 30, 2024 | 72.90B | -14.68% |
| Dec 28, 2023 | 85.44B | -16.84% |
| Dec 29, 2022 | 102.75B | -21.01% |
| Dec 30, 2021 | 130.08B | 20.22% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SAMSUNG PHARM. Co., LTD. | 124.62B |
| HANDOK | 123.54B |
| Jeil Pharma Holdings | 114.37B |
| HLB Pharmaceutical | 101.53B |
| CMG Pharmaceutical | 86.50B |
| CKD Bio | 77.57B |
| Enzychem Lifesciences | 76.86B |
| Ildong Holdings | 74.19B |